Analyze Your Search


  • Action links for each search result record
    • Bookmark: Allows you to Bookmark the page for easy future retrieval 
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • More Info: Shows full summary of content record
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Follow" button to the right of the search box. 
Colorectal Cancer
  Follow Topic   Edit Search
Your search returned 91 results
from the time period: last 12 months.
Sort by Relevance / Date Group By Journal / No Grouping
JAMA surgery 
... of oral antibiotics to MBP with preventing SSIs in left colon and rectal cancer resections and its association with the timely administration of adjuvant ... A retrospective review was performed of 89 patients undergoing left colon and rectal cancer resections from October 1, 2013, to December 31, 2016, at ... SSIs and should be considered for patients undergoing elective left colon and rectal cancer resections.
Infectious Diseases (16), Oncology (6)
Rectal Neoplasms (4), Infections (3), Anastomotic Leak (2), more mentions
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 
DescriptorName: Blood Vessels. DescriptorName: Colorectal Neoplasms... Abstract: Purpose Colorectal cancer (CRC) treatment is largely determined by tumor stage. Despite improvements made in the treatment of various types of metastatic disease, staging has not been refined. The role of tumor deposits (TDs) in staging remains debated. We have assessed the relation of TDs with metastatic pattern to evaluate whether TDs might ...
Oncology (8)
Neoplasms (4), Colorectal Neoplasms (3), Lung Neoplasms (1), more mentions
Lancet (London, England) 
... in patients with a good response after chemoradiotherapy for lower rectal cancer AbstractText: We did a prospective, randomised, open-label, multicentre, phase ... centres in France that were experts in the treatment of rectal cancer. Patients aged 18 years and older with stage T2T3 lower rectal carcinoma, of maximum size 4 cm, who had a good clinical ...
Oncology (5)
Rectal Neoplasms (4), Carcinoma (1), Neoplasms (1), more mentions
DescriptorName: Rectal Neoplasms... AbstractText: Robotic rectal cancer surgery is gaining popularity, but limited data are available regarding ... of conversion to open laparotomy among patients undergoing resection for rectal cancer AbstractText: Randomized clinical trial comparing robotic-assisted vs conventional laparoscopic ... to robotic-assisted (n = 237) or conventional (n = 234) laparoscopic rectal cancer resection, performed by either high (upper rectum) or low (total ...
Oncology (5), Men's Health (2)
Rectal Neoplasms (6), Adenocarcinoma (2), more mentions
The Cochrane database of systematic reviews 
DescriptorName: Colorectal Neoplasms... is an update of the Cochrane review published in 2002.Colorectal cancer (CRC) is a major cause of morbidity and mortality in ... intervention AbstractText: We identified randomised controlled trials (RCTs) from Cochrane Colorectal Cancer's Specialised Register, CENTRAL, MEDLINE and Embase (search date, 4 April ... The results on the number of participants diagnosed with colorectal cancer favoured the control group over the dietary fibre group (2 ...
Oncology (10)
Adenoma (12), Adenomatous Polyps (7), Colorectal Neoplasms (4), more mentions
AbstractText: Previous studies reported that black vs white disparities in survival among elderly patients with colorectal cancer (CRC) were due to differences in tumor characteristics (tumor stage, grade, nodal status, and comorbidity) rather ... populations could substantially reduce differences in survival times of black vs white patients with CRC Keyword: colon cancer.
Oncology (13)
Neoplasms (11), Colorectal Neoplasms (2), Colonic Neoplasms (1), more mentions
BMJ (Clinical research ed.) 
... To compare the effectiveness of flexible sigmoidoscopy in screening for colorectal cancer by patient sex and age AbstractText:  Pooled analysis of randomised trials (the US Prostate, Lung, Colorectal and Ovarian cancer screening trial (PLCO), the Italian Screening for Colon and Rectum trial (SCORE), and the Norwegian Colorectal Cancer Prevention trial (NORCCAP)) AbstractText:  Aggregated data were pooled from each randomised trial on incidence of colorectal cancer and mortality stratified by sex, age at screening, and ...
Oncology (10)
Colorectal Neoplasms (9), Ovarian Neoplasms (1), Neoplasms (1), more mentions
The lancet. Gastroenterology & hepatology 
... free survival and overall survival in patients with stage III colon cancer... with capecitabine as adjuvant treatment in patients with stage III colorectal cancer AbstractText: This study was an open-label, non-inferiority, randomised ... a minimisation method with a random component adjusted by institution, tumour location (colon vs rectosigmoid and upper rectum), number of positive lymph node ...
Oncology (6)
Colorectal Neoplasms (3), Neutropenia (1), Adenocarcinoma (1), more mentions
CitationSubset: AIM. CitationSubset: IM. DescriptorName: Adult. DescriptorName: Biopsy. DescriptorName: Colitis, Ulcerative. DescriptorName: Colon. DescriptorName: Colonoscopy. DescriptorName: Colorectal Neoplasms... AbstractText: Inflammatory bowel diseases (IBDs) increase the risk of colorectal cancer... Trial no: ACTRN12616000047493 Keyword: Colon Cancer. Keyword: Crohn’s Disease. Keyword: FUSION Study. Keyword: Neoplasm.
Oncology (3)
Colorectal Neoplasms (2), Colitis (2), Neoplasms (2), more mentions
The Lancet. Oncology 
DescriptorName: Prognosis. DescriptorName: Rectal Neoplasms... AbstractText: Radiotherapy reduces the risk of local recurrence in rectal cancer. However, the optimal radiotherapy fractionation and interval between radiotherapy and surgery is still under debate. We aimed to study recurrence in patients randomised between three different radiotherapy regimens with respect to fractionation and time to surgery AbstractText: In this multicentre, randomised, non-blinded, phase ...
Oncology (6)
Neoplasms (4), Rectal Neoplasms (3), Adenocarcinoma (2), more mentions
Annals of surgery 
DescriptorName: Rectal Neoplasms... is occasionally found in clinical stage II or III lower rectal cancer, and ME with LLND is the standard procedure in Japan ... ME alone, however, is the international standard surgical procedure for rectal cancer AbstractText: Eligibility criteria included histologically proven rectal cancer at clinical stage II/III; main lesion located in the ...
Oncology (8)
Rectal Neoplasms (5), Neoplasms (2), Lymphatic Metastasis (1), more mentions
Annals of surgery 
... surgery with those of laparoscopic surgery in the patients with rectal cancer AbstractText: The feasibility of robot-assisted surgery over laparoscopic surgery for rectal cancer has not been established yet AbstractText: Between February 21, 2012 and March 11, 2015, patients with rectal cancer (cT1-3NxM0) were enrolled ... the laparoscopic group (P = 0.03) AbstractText: Robot-assisted surgery in rectal cancer showed TME quality comparable with that of laparoscopic surgery, and ...
Oncology (6)
Rectal Neoplasms (5), Neoplasms (1), more mentions
JAMA oncology 
... of DNA has been observed in up to 15% of sporadic colorectal cancers (CRCs) and is a characteristic feature of Lynch syndrome, which has ... vs academic/research facility type (OR, 0.44; 95% CI, 0.34-0.56); rectosigmoid or rectal tumor location (OR, 0.76; 95% CI, 0.68-0.86); unknown grade (OR, 0.61 ...
Oncology (7)
Neoplasms (3), Colorectal Neoplasms (1), Rectal Tumors (1), more mentions
The Lancet. Oncology 
DescriptorName: Colorectal Neoplasms... radiotherapy (SIRT) in third-line or subsequent therapy for metastatic colorectal cancer has clinical benefit in patients with colorectal liver metastases with ... SIRT using yttrium-90 resin microspheres in patients with metastatic colorectal cancer with liver metastases... Chemotherapy-naive patients with metastatic colorectal cancer (WHO performance status 0 or 1) with liver metastases not ...
Oncology (8)
Colorectal Neoplasms (8), Neutropenia (1), Liver Neoplasms (1), more mentions
The American journal of gastroenterology 
OBJECTIVES: The objective of this study was (a) To know the prevalence and distribution of extracolonic cancer (EC) in patients with inflammatory bowel disease (IBD); (b) To estimate the incidence rate of EC; (c) To evaluate the association between EC and treatment with immunosuppressants and anti-tumor necrosis factor (TNF) agents. METHODS: This was an observational cohort study. INCLUSION CRITERIA: IBD and inclusion in the ENEIDA Project (a prospectively maintained registry) from GETECCU. EXCLUSION CRITERIA: Patients with EC before the diagnosis of IBD, lack of relevant data for this study, and previous treatment with immunosuppressants other than corticosteroids, thiopurines, methotrexate, or anti-TNF agents. The Kaplan-Meier method was used to evaluate the impact of several variables on the risk of EC, and any differences between survival curves were evaluated using the log-rank test. Stepwise multivariate Cox regression analysis was used to investigate factors potentially associated with the development of EC, including drugs for the treatment of IBD, during follow-up. RESULTS: A total of 11,011 patients met the inclusion criteria and were followed for a median of 98 months. Forty-eight percent of patients (5,303) had been exposed to immunosuppressants or anti-TNF drugs, 45.8% had been exposed to thiopurines, 4.7% to methotrexate, and 21.6% to anti-TNF drugs. The prevalence of EC was 3.6%. In the multivariate analysis, age (HR=1.05, 95% CI=1.04-1.06) and having smoked (hazards ratio (HR)=1.47, 95% confidence interval (CI)=1.10-1.80) were the only variables associated with a higher risk of EC. CONCLUSIONS: Neither immunosuppressants nor anti-TNF drugs seem to increase the risk of EC. Older age and smoking were associated with a higher prevalence of EC.
Oncology (2)
Neoplasms (5), Inflammatory Bowel Diseases (3), Necrosis (2), more mentions
The Cochrane database of systematic reviews 
DescriptorName: Colorectal Neoplasms... AbstractText: The therapeutic management of people with metastatic colorectal cancer (CRC) who did not respond to first-line treatment represents a formidable challenge AbstractText: To determine the efficacy and toxicity of second-line systemic therapy in people with metastatic CRC AbstractText: We searched the Cochrane Central Register ...
Oncology (8)
Colorectal Neoplasms (3), more mentions
Techniques in coloproctology 
... a meta-analysis of relevant studies whether or not the wall defect following TLE of rectal tumors should be closed AbstractText: Medline and the Cochrane Trials Register were searched for trials published ... December 2016 comparing open versus closed management of the surgical rectal defect after TLE of rectal tumors... Keyword: Rectal tumor.
Rectal Tumors (4), Infections (1), Neoplasms (1), more mentions
JAMA surgery 
... Rectal resection with mesorectal excision is the mainstay treatment for rectal cancer AbstractText: To review and analyze the evidence concerning the pathologic ... outcomes of laparoscopic (LRR) vs open (ORR) rectal resection for rectal cancer AbstractText: The Cochrane Central Register of Controlled Trials, MEDLINE (through ... 30, 2016, that compared LRR with ORR for histologically proven rectal cancer in adult patients and reported pathologic outcomes (eg, positive circumferential ...
Oncology (5)
Rectal Neoplasms (6), Neoplasms (1), more mentions
Cell reports 
Abstract: The tumor suppressor gene adenomatous polyposis coli (APC) is mutated in most colorectal cancers (CRCs), resulting in constitutive Wnt activation... Keyword: colorectal cancer. Keyword: ubiquitination. Keyword: β-catenin.
Oncology (3)
Neoplasms (5), Colorectal Neoplasms (2), Adenomatous Polyposis Coli (1), more mentions
JAMA oncology 
We previously showed in a randomized trial that high EGFR ligand expression is predictive of panitumumab benefit in advanced colorectal cancer... samples from the PICCOLO trial that tested the addition of panitumumab to irinotecan therapy in patients with KRAS wt advanced colorectal cancer who experienced failure with prior fluoropyrimidine treatment.
Oncology (3)
Neoplasms (4), Colorectal Neoplasms (3), more mentions
1 2 3 4 5  | Next Page»